GlaxoSmithKline Pharmaceuticals
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Pharmaceuticals
Nine Months of GlaxoSmithKline Pharmaceuticals |
------------------- in Rs. Cr. ------------------- |
 |
|
|
Sep '05 |
Sep '06 |
Sep '07 |
Sep '08 |
Sep '09 |
|
| Sales Turnover |
1,152.64 |
1,226.53 |
1,231.07 |
1,312.64 |
1,441.21 |
| Other Income |
44.67 |
65.90 |
92.26 |
34.97 |
57.98 |
| Total Income |
1,197.31 |
1,292.43 |
1,323.33 |
1,347.61 |
1,499.19 |
| Total Expenses |
790.90 |
831.97 |
827.08 |
822.78 |
950.09 |
| Operating Profit |
361.74 |
394.56 |
403.99 |
489.86 |
491.12 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
204.66 |
184.16 |
139.91 |
-- |
10.53 |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
406.41 |
460.46 |
496.25 |
524.83 |
549.10 |
| Interest |
-- |
-- |
-- |
-40.26 |
-62.44 |
| PBDT |
611.07 |
644.62 |
636.16 |
565.09 |
622.07 |
| Depreciation |
11.32 |
11.74 |
11.14 |
11.61 |
11.62 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
599.75 |
632.88 |
625.02 |
553.48 |
610.45 |
| Tax |
140.05 |
155.16 |
168.26 |
185.38 |
201.75 |
| Net Profit |
459.70 |
477.72 |
456.76 |
368.10 |
408.70 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
54.27 |
56.40 |
53.93 |
43.46 |
48.25 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
84.70 |
84.70 |
84.70 |
84.70 |
84.70 |
| Reserves |
-- |
-- |
-- |
-- |
-- |
| Face Value |
10.00 |
10.00 |
10.00 |
10.00 |
10.00 |
|
|
|
|
| Source : Religare Technova |
| Explore GlaxoSmithKline connections |
|
